Definiens Receives Frost & Sullivan Award for Technology Leadership in the High Content Screening Market

Munich, Germany / Morristown, NJ, USA – September 17th, 2007 - Definiens, the number one Enterprise Image Intelligence™ company, today announced the receipt of Frost & Sullivan’s 2007 U.S. Award for Technology Leadership in the high-content screening market. Frost & Sullivan presents this Award to the company that has demonstrated unparalleled excellence for providing innovative and enabling high-content screening technology. The business research and consulting firm has cited Definiens because it excels in all stages of technology life cycle - incubation, adaptation, take-up and maturity – in its efforts to ensure ongoing technology improvements.

Frost & Sullivan has rewarded Definiens for its innovative technology and the Definiens Cellenger® software used in high-content analysis. Current high-content analysis software provides data based on two dimensional images, while Definiens' technology strategy focuses on developing software that will enable three dimensional (3D) and four dimensional (4D) image analysis. Tracking of cells in 3D over time (i.e., 4D) provides useful data regarding cell morphology and structure, including correlating cell speed changes and movement. With 3D and 4D capabilities, the analysis of cellular processes over time will be possible, a ground-breaking improvement compared to static and flat snapshots provided by 2D.

“Part of the Definiens Enterprise Image Intelligence Suite, Definiens Cellenger allows life sciences organizations to speed up the drug development cycle,” notes Frost & Sullivan Industry Analyst Jonathan Witonsky. “Definiens enables researchers to more efficiently identify and understand the interesting pathways and mechanisms that give rise to the screening responses”.
Definiens’ management was delighted to receive the Frost & Sullivan technology leadership award. “To be recognized by Frost & Sullivan for technology leadership demonstrates that we are on track to become the standard in image analysis,” said Greg Calaman, Vice President North American Operations at Definiens when accepting the award at the Growth Excellence Awards Banquet in Monterey, California. “The Frost & Sullivan’s research methodology also reflects the acceptance of the Definiens Enterprise Image Intelligence Suite by our growing base of customers which are solving vast arrays of image analysis problems during all stages of the drug development lifecycle”.

Definiens, Definiens Cellenger, Definiens Cognition Network Technology, Definiens eCognition, Enterprise Image Intelligence and Understanding Images are trademarks or registered trademarks of Definiens. All other names are the trademarks or registered trademarks of their respective companies.

Press contacts:
Definiens
Rene Hermes
Vice President Marketing
rhermes@definiens.com
+49 (0)89 231180-11

Lucy Turpin Communications
Nina Wenske
PR & MarCom Manager
definiens@lucyturpin.com
+49 (0)89 417761-13

Frost & Sullivan
Stacie Jones
Stacie.jones@frost.com
+1 210 247 2450

About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit www.awards.frost.com.

Definiens in Life Sciences
By automating image analysis on an enterprise level, Definiens supports Life Science organizations to analyze and interpret vast numbers of images accurately and consistently. Definiens improves the measurement of cell assays, the examination of tissue samples and the interpretation of non-invasive imaging, enabling high-content screening, digital pathology and translational medicine.

About Definiens
Definiens is the number one Enterprise Image Intelligence company for analyzing and interpreting images on every scale, from microscopic cell structures to satellite images. The Definiens Cognition Network Technology®, developed by Nobel laureate Prof. Gerd Binnig and his team, is an advanced and robust context-based technology designed to fulfill the image analysis requirements of the Life and Earth sciences markets. The technology is modeled on the powerful human cognitive perception processes to extract intelligence from images. Definiens provides organizations with faster image analysis results, allowing deeper insights enabling better business decisions. The company is headquartered in Munich, Germany and has offices throughout the United States. Further information is available at www.definiens.com.

This release was published on openPR.